Brief: BB Biotech FY Net Loss At CHF 405 Mln

Bb Biotech

18/02/2022 06:06

Feb 18 (Reuters) - BB BIOTECH AG  BION.S :
    * CONSOLIDATED AND AUDITED FULL YEAR 2021 DATA SHOWED A NET
LOSS
OF CHF 405 MN COMPARED TO A NET GAIN OF CHF 691 MN FOR 2020
    * FOR FULL YEAR, TOTAL SHARE RETURN WAS +8.3% IN CHF AND
+13.3% IN
EUR, SUBSTANTIALLY AHEAD OF PORTFOLIO PERFORMANCE OF -11.5% IN
CHF, -7.8% IN EUR AND -14.2% IN USD
    * WILL PROPOSE A DIVIDEND OF CHF 3.85 PER SHARE AT UPCOMING
ANNUAL
GENERAL MEETING

Source text for Eikon:  ID:nEQ69gbR0a 
Further company coverage:  BION.S 

 (Gdansk Newsroom)
 ((Gdansk.Newsroom@thomsonreuters.com;))